World’s First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical

B CHONGQING, China, April 28, 2026 /PRNewswire/ — Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China’s National Medical Products Administration (NMPA) has approved…
posteditor
posteditor
Articles: 17424

Other News